Liposorber

03/24/2026

Today is Lp(a) Awareness Day 🧡- a moment to shine a light on lipoprotein(a), which is a type of low-density lipoprotein (LDL) or “bad” cholesterol. Elevated Lp(a) is a common, inherited condition that can significantly increase the risk of early heart disease and stroke.

1 in 5 people in the United States are impacted by elevated Lp(a). Because Lp(a) is genetic, it can’t be lowered through diet or exercise alone and often goes undetected. The only way to understand your risk is through a simple blood test, a once in a lifetime guideline-recommended test, that can provide critical insight into heart health.

Join us today in raising awareness and encouraging testing so more people can .

To learn more, visit: familyheart.org/lpa-awareness-day



Reference: “About Lipoprotein(a)” Centers for Disease Control and Prevention, 10 Sep. 2025, www.cdc.gov/heart-disease-family-history/about/about-lipoprotein-a.html?CDC_AAref_Val=https://www.cdc.gov/genomics/disease/lipoprotein_a.htm

03/23/2026

We’re excited to connect with the cardiology community at ACC.26 on March 28-30 in New Orleans!

Visit with the Liposorber team at Booth #206 to learn more about the role of lipoprotein apheresis in managing patients with severe, refractory hypercholesterolemia, especially those who remain at high cardiovascular risk despite maximally tolerated therapy.

📍 See you at ACC.26.

For LIPOSORBER Indications for Use and other safety information, please visit: liposorber.com/liposorber-safety-info

03/20/2026

LIPOSORBER provides a proven alternative for patients with severe cholesterol or kidney disease when standard drug therapies fail. This FDA-approved system selectively removes harmful LDL cholesterol and Lp(a) directly from the blood to help reduce cardiovascular risks and manage conditions like FSGS.*

For LIPOSORBER Indications for Use and other safety information, please visit: liposorber.com/liposorber-safety-info

*LIPOSORBER is authorized for use in FSGS patients under a Humanitarian Device Exemption. For LIPOSORBER Indications for Use and other safety information, please visit: liposorber.com/liposorber-safety-info

03/16/2026

Meet Salima! Here's her story:

“Living with FH and not knowing was terrifying. Today, I’m grateful to say that with the right doctors and the right medication, life feels possible—and I’m beating the odds.

When LDL apheresis became an option for me, I had no idea what lay ahead. Almost four years into treatment, I can truly say that life is possible. My weekly treatments can be exhausting, but with rest and perseverance, I’m living my best life and continuing to fight.

I was truly blessed the day Angela from Kaneka introduced us to this incredible apheresis machine that is saving my life. My deepest thanks to my Northwell team—Dr. Mintz, NP Jessica, and my amazing nurses Diana, Nicole, Amanda, Ambia, Mohini, and Lily—for standing by me and helping me fight this awful disease. Thank you all from the bottom of my heart ❤️.”

For LIPOSORBER Indications for Use and other safety information, please visit: liposorber.com/liposorber-safety-info

03/12/2026

On World Kidney Day, we recognize patients, care partners, and clinicians working to improve outcomes in complex kidney diseases.

For people living with focal segmental glomerulosclerosis (FSGS), kidney damage can lead to nephrotic syndrome and significant protein loss, increasing the risk of long-term kidney failure.

Liposorber® is an LDL-C apheresis system indicated for treatment of select cases of drug-resistant FSGS under a Humanitarian Device Exemption.*

Together, raising awareness is the first step toward earlier diagnosis, informed care decisions, and better kidney health.

💚 Learn more. Start the conversation. Support kidney care.

*LIPOSORBER is authorized for use in FSGS patients under a Humanitarian Device Exemption. For LIPOSORBER Indications for Use and other safety information, please visit: liposorber.com/liposorber-safety-info

03/10/2026

Dr. Mintz is a leading cardiologist at Northwell Health, where he serves as Director of Cardiovascular Health and Lipidology and Co‑Director of the Lipid Center. With decades of experience, he is dedicated to helping patients prevent and manage heart disease through personalized, compassionate care.

A nationally recognized expert in cholesterol management and preventive cardiology, Dr. Mintz also teaches future clinicians and has been honored repeatedly as a Castle Connolly Top Doctor. He frequently lectures on heart health, hypertension, inflammation, and reducing cardiac risk.

After founding his own practice in 1989, he joined the Sandra Atlas Bass Heart Hospital to expand patient access to advanced heart and lipid therapies, including LDL-C apheresis (Liposorber). His commitment to patients and their families remains at the heart of his work every day.

Discover LIPOSORBER, the FDA-approved clinical therapy and proven alternative for lowering high cholesterol levels (LDL-C, Lp(a)) when maximum drug therapies don't work.

03/06/2026

The countdown is on for the OEIS 2026 Annual Meeting, held on March 19-21 in Las Vegas!

We’re excited to join the OEIS community to discuss advancements in lipid management and the role of Liposorber therapy for patients who need more than conventional treatment. Be sure to connect with our team and learn more about lipoprotein apheresis: Booth #202

👋 We look forward to seeing you there!

For LIPOSORBER Indications for Use and other safety information, please visit: liposorber.com/liposorber-safety-info

Discover LIPOSORBER, the FDA-approved clinical therapy and proven alternative for lowering high cholesterol levels (LDL-C, Lp(a)) when maximum drug therapies don't work.

03/03/2026

Diana Flax is a registered nurse who began her career in intensive care before transitioning into the specialized role of an Apheresis nurse. She now serves as a lead nurse helping to grow the LDL-C Apheresis program at North Shore University Hospital, where she plays a key role in both clinical care and program development.

Diana is deeply passionate about onboarding and welcoming new patients into the program, building meaningful relationships with those she sees every week, and guiding them through a truly lifesaving treatment. She finds great fulfillment in being part of her patients’ long-term care journeys and making a direct impact on their quality of life.

02/28/2026

Today is Rare Disease Day! On this day, we shine a light on the millions of people living with rare conditions—and the healthcare professionals working tirelessly to support them.

At LIPOSORBER, we are committed to improving lives for patients with Familial Hypercholesterolemia (FH) and Focal Segmental Glomerulosclerosis (FSGS)—two rare but serious conditions that require specialized care.

Together, we can raise awareness, advance research, and ensure that no patient feels alone in their journey.

Learn more about FH and FSGS and how LIPOSORBER® helps make a difference: Liposorber.com

For LIPOSORBER Indications for Use and other safety information, please visit:
liposorber.com/liposorber-safety-info

To learn more about how you can support Rare Disease Day, visit: rarediseaseday.org

02/25/2026

Our latest newsletter highlights February as Heart Awareness Month: Join 17 yr old Avery as she shares her powerful HoFH story + Dr. Martin speaks on how genetic drivers of CV risk are often underrecognized https://mailchi.mp/kaneka/liposorbernewsletter-feb2026

02/23/2026

Advancing Apheresis in San Diego!

Join us at the 13th Annual UC San Diego Essentials & Advances in Apheresis Therapies, taking place March 5–7 at the Catamaran Resort Hotel.

This meeting is a hub for the latest innovations in therapeutic apheresis. Visit the Kaneka booth to explore our cutting-edge technologies and discuss the clinical benefits of targeted lipoprotein removal for complex patient populations.

Whether you're a first-time attendee or a returning participant, we look forward to connecting with you in San Diego!

📍 Where: Catamaran Resort Hotel, San Diego, CA
📅 When: March 5–7, 2026
🔗 https://ucsd.cloud-cme.com/course/courseoverview?P=0&EID=15630

For LIPOSORBER Indications for Use and other safety information, please visit:
liposorber.com/liposorber-safety-info

02/23/2026

LIPOSORBER is officially available at Sorin Medical P.C. 👏🙌